Dipeptidyl peptidase-4 inhibitors and their potential role in the management of atherosclerosis—A review
Abstract Background Dipeptidyl peptidase-4 (DPP-4) inhibitors are a relatively new class of
anti-diabetic drugs that have therapeutic potential in the management of atherosclerosis. Of
the numerous DPP-4 inhibitors in clinical practice no studies have been conducted to
compare their anti-atherosclerotic effects despite growing evidence of their usefulness in the
high risk population. Objective The aim of the study was to review the anti-athero-thrombotic
effects of DPP-4 inhibitors in atherosclerotic diseases. Method A literature search was …
anti-diabetic drugs that have therapeutic potential in the management of atherosclerosis. Of
the numerous DPP-4 inhibitors in clinical practice no studies have been conducted to
compare their anti-atherosclerotic effects despite growing evidence of their usefulness in the
high risk population. Objective The aim of the study was to review the anti-athero-thrombotic
effects of DPP-4 inhibitors in atherosclerotic diseases. Method A literature search was …